Cardiometabolic disease, a term encompassing a cluster of conditions that increase the risk of cardiovascular disease and metabolic disorders, represents a significant health challenge in today's society. This multifaceted group includes conditions such as obesity, type 2 diabetes, and hypertension, which collectively contribute to an elevated risk of heart disease and stroke. The intricate interplay between genetics, lifestyle factors, and environmental influences underscores the complexity of cardiometabolic diseases. Sedentary lifestyles, poor dietary choices, and genetic predispositions can contribute to the development and progression of these interconnected conditions. Early detection and comprehensive management strategies are crucial in mitigating the impact of cardiometabolic disease, emphasizing the importance of lifestyle modifications, medication adherence, and regular health screenings. Public health initiatives aimed at promoting awareness, education, and preventive measures play a pivotal role in addressing the rising prevalence of cardiometabolic disease and fostering a healthier population.
Title : A diabetic sweetheart facing a sour ending!
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Perception of cardiovascular risk in women after a rehabilitation program
Maria Teresa Carvallo Marin, Privado, Chile